Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2d3599fb8f8f479dba95ca9bb504884 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-195 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7042 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-381 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-381 |
filingDate |
2014-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f707ed40091f3dd0bc769d18f671c0a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4475696dfd508658fed4bc701429d6c3 |
publicationDate |
2016-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2016022632-A1 |
titleOfInvention |
Combination of canagliflozin and probenecid for the treament of hyperuricemia |
abstract |
The present invention is directed to methods for treating hyperuricemia and related disorders, comprising co-therapy with canagliflozin and probenecid. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112739330-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11554112-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11478428-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112957318-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11547685-B2 |
priorityDate |
2013-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |